Ticker League

Vertex Pharmaceuticals (VRTX) Income Statement Waterfall

Follow every dollar of Vertex Pharmaceuticals's revenue down to net income — how much COGS, OpEx, and taxes each consume, and the margin that survives at every step.

TTM

Revenue

$12.26B

Gross Margin

+86.3%

Operating Margin

+39.0%

Net Margin

+35.4%

Income statement waterfall for Vertex Pharmaceuticals (VRTX) — TTM through Q1 2026

Net income: $4.34B

Margin breakdown for Vertex Pharmaceuticals (VRTX) — TTM through Q1 2026

  • Revenue$12.26B
  • Cost of Revenue−$1.68B
  • Gross Profit$10.57B
  • Operating Expenses−$5.80B
  • Operating Income$4.78B
  • Other Income / Expense$389.90M
  • Pre-tax Income$5.17B
  • Income Tax−$827.40M
  • Net Income$4.34B
Want to see what changed vs last year?Profit Bridge

Frequently asked questions

Data & methodology